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Abstract: Hydroxyapatite (HA) has been widely investigated as scaffolding material for 
bone tissue engineering, mainly for its excellent biocompatibility. Presently, there is an 
increasing interest in the composites of hydroxyapatite with bioactive glasses, with the aim 
to obtain systems with improved bioactivity or mechanical properties. Moreover, 
modifying the ratio between bioactive glass and hydroxyapatite results in the possibility of 
controlling the reaction rate of the composite scaffold in the human body. However, high 
temperature treatments are usually required in order to sinter HA-based composites, 
causing the bioactive glass to crystallize into a glass-ceramic, with possible negative 
effects on its bioactivity. In the present research work, a glass composition belonging to the 
Na2O-CaO-P2O5-SiO2 system, with a reduced tendency to crystallize, is applied to realize 
HA-based composites. The novel samples can be sintered at a relative low temperature 
(750 °C) compared to the widely studied HA/45S5 Bioglass
®
 composites. This fact greatly 
helps to preserve the amorphous nature of the glass, with excellent effects in terms of 
bioactivity, according to in vitro tests. As a first application, the obtained composites are 
also tested to realize highly porous scaffolds by means of the standard burning out method. 
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1. Introduction  
Bone tissue engineering [1-3] is an emerging biomedical technology aiming to develop alternative 
protocols for bone tissue repair and regeneration. In a typical application, tissue is harvested from the 
patient and then it is dissociated into individual cells using enzymes. The cells are then seeded on a 
scaffold [4-6], i.e., a proper porous structure which acts as a guide for tissue re-growth in three 
dimensions, obtaining a living bio-composite system. From this point of view, scaffolds are artificial 
structures designed as temporary templates for cell adhesion and proliferation. The damaged tissue is 
removed from the patient body and the tissue/scaffold composite is reimplanted in the defect site of the 
patient, where the scaffold will be resorbed while the cells are producing their own natural 
extracellular matrix. To be useful, scaffolds should be highly bioactive and mimic the human bone 
morphology, which is highly porous with an interconnected pore network [7-9]. The pore structure is 
necessary for the infiltration of cells into the scaffold, for the supply of nutrients and fluids, and the 
washout of cell wastes. The scaffold material should also be able to promote cell adhesion and, ideally, 
at least to stimulate osteogenesis at the genetic level [10,11]. At the same time, adequate mechanical 
properties are required for scaffolds, in order to match those of the tissue to be restored. Moreover, it is 
highly desirable to optimally control the reaction rate of the scaffold in the human body, which is 
expected to range from a slightly bioactive behavior to a quick and complete bioresorption with 
appropriate degradation properties depending on the specific application [12,13]. 
In the last years, scaffolds based on synthetic calcium phosphate bioceramics, such as β-tricalcium 
phosphate (β-TCP) and, in particular, hydroxyapatite (HA), have been realized by means of different 
techniques [14,15]. The main advantage of HA (Ca10(PO4)6(OH)2) is its chemical similarity to the 
mineral component of natural bone, which promotes the ability to form a bond with the surrounding 
bone tissue when implanted. For these reasons, HA gained acceptance as a bone substitute and it is 
nowadays employed in oral, maxillofacial and orthopaedic applications [16-18]. On the other hand, 
even if the HA biocompatibility is excellent, its reactivity with the existing bone is low, therefore the 
rate at which the bone integrates with HA is relatively low [19]. These facts can be detrimental for 
scaffold applications. 
There have been many attempts to combine HA with other bioceramics, in order to produce 
composite materials with improved biological properties [20,21]. Recently, the interest of many 
material scientists has been focused on the possibility to sinter HA with bioactive-glass addictions. The 
particular composition of bioactive glasses (or bioglasses), originally discovered by Hench and 
coworkers at the end of the 1960s, makes them highly reactive when in contact with body fluids. As a 
consequence, bioglasses are able to build tenacious bonds with the surrounding bone, through the 
formation of a surface layer of hydroxy-carbonate apatite (HAC) which drives and promotes 
osteogenesis, allowing the rapid formation of new bone [22,23]. Compared with bioactive glasses, HA 
and β-TCP are characterized by more bland surface reactions and minimal ionic release [19]. The 
addition of such glasses to HA is expected to improve not only the bioactivity of the system, but also 
its sinterability, since bioactive glasses typically melt at a lower temperature compared to HA; the 
glassy phase, when incorporated into HA in order to obtain composite materials, enhances the 
densification and the resulting mechanical strength. 
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Several bioglasses of different compositions have already been tested in HA-based composites. Many 
of them belong to the Na2O-CaO-P2O5 or CaO-P2O5-SiO2 systems [24-27]. In particular the 45S5 
Bioglass
®
 [22], whose reference proportions (46.1 mol % SiO2, 26.9 mol % CaO, 24.4 mol % Na2O 
and 2.6 mol % P2O5) make it able to bond to both hard and soft tissues, has been used [28]. 
On the other hand, among the disadvantages of using bioglasses in HA-based composites, it should 
be noted that, in spite of the sintering aid exerted by the glass, high-temperature treatments are often 
required in order to sinter these systems. The usual sintering processes, performed in a range of 
temperatures between 1200 °C and 1300 °C, cause the HA to decompose, with subsequent formation of 
tricalcium phosphate or CaO [29]. Additionally, at such temperatures, reactions occur between the HA 
and the glass, which provoke a reduction in the HA amount, an alteration of the lattice parameters of the 
residual HA, and the development of new phases, such as α- and β-tricalcium phosphate (TCP) [30]. 
The presence of α- or β-TCP should be avoided, since it alters the biodegradability of the final 
system. On the other hand, CaO and the subsequent formation of Ca(OH)2 may cause decohesion of 
the composite, because of the stresses due to volume changes [31]. It should also be noted that high 
temperature treatments may cause the bioactive glass to crystallize into a glass-ceramic prior to 
complete densification, with possible negative effects on its bioactivity [32]. The bioactivity of these 
materials, in fact, is based both on their composition and on their inherently amorphous nature, which 
facilitates the solubility both in vitro and in vivo. These considerations, among others, initially led 
materials scientists to look with pessimism on the feasibility of highly porous bioglass-based scaffolds. 
For example, Li [32] and coworkers reported a HAC layer formation in vitro only with a high 
proportion (over 90%) of glassy phase in the glass-ceramic sample. However, the findings of various 
studies on 45S5 Bioglass
®
-derived glass ceramics show that crystallization decreases the kinetics of 
the HAC layer formation without inhibiting the development of such a layer [4,33]. For these reasons, 
the development of glass compositions with a reduced tendency to crystallize is desired for the 
production of scaffolds and, in general, HA-based composites, since the rate of HAC formation and, 
presumably, the system bioactivity, decrease when the percentage of crystallization increases [33,34].  
In this work, a specific glass composition (BG_Ca), whose proportions are 47.3 mol % SiO2,  
45.6 mol % CaO, 4.6 mol % Na2O and 2.6 mol % P2O5, is applied to realize HA-based composites 
(HA/BG_Ca) [35]. This glass shows a low tendency to crystallize compared to the widely used 45S5 
Bioglass
®
, which belongs to the same Na2O-CaO-P2O5-SiO2 system. Most of all, BG_Ca pressed 
powders are characterized by the ability to consolidate at rather low temperatures (750 °C), before the 
crystallization starts, with positive effect on the resulting bioactivity. It should be noted that such a 
heat treatment results in a cheaper technological protocol; on the other hand, it is possible to prevent 
the hydroxyapatite decomposition, which typically occurs at higher temperatures.  
In the first part of this feasibility study, the bioactivity of the novel HA/BG_Ca samples was tested 
in a simulated body fluid solution (SBF) [36]. Afterwards, HA/BG_Ca powders were used to produce 
composite scaffolds by means of the polymer burning out method [37,38]. This technique, which is 
probably the simplest way to generate porous scaffolds from ceramics, employs organic fillers as pore 
generating agents in a ceramic matrix. The organic phase is added to the ceramic powders and then it 
is thermally removed during sintering. This method has the advantage of combining versatility and low 
cost. The obtained scaffolds were analyzed from a microstructural point of view, paying particular 
attention to their porosity (content and morphology). The realized scaffolds possessed a good 
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manageability and an adequate porous structure, together with an appreciable mechanical behavior, 
according to compression tests.  
2. Materials and Methods 
2.1. HA/BG_Ca Composites Preparation 
The BG_Ca was prepared by melting the raw powder materials (commercial SiO2, CaCO3, 
Ca3(PO4)2, Na2CO3 by Carlo Erba Reagenti, Italy) in a platinum crucible. The following thermal cycle 
was set: from room temperature to 1100 °C at 10
 
°C /min; at 1100 °C for 1 h; from 1100 °C to 1450 °C 
at 10 °C /min; at 1450 °C for 30 min. Then the melt was rapidly quenched in water. The obtained frit 
was dried overnight in a furnace at 110 °C, ball-milled and finally sieved to a grain size below 38 m.  
BG_Ca powders were mixed by 50 wt % with HA powders to obtain the HA/BG_Ca composite. 
Commercial HA (CAPTAL

 Hydroxylapatite, Plasma Biotal Ltd, U.K.), with an average particle size 
below 25 m, was used. HA/BG_Ca powders were mixed for 6 h in a plastic bottle using a rolls shaker 
in order to obtain an effective mixing. Then the powders were used to produce green bodies by 
uniaxial pressing at 140 MPa for 10 s using propanol as a liquid binder. The pressed samples, shaped 
in form of disks (4 cm of nominal diameter, 0.7 cm of thickness), were heat-treated for 3 h in a 
furnace. Various sintering temperatures were considered and the densification of the composites was 
monitored by measuring the Archimedean density and the volume shrinkage. The thermal treatment 
was set at a final temperature of 750 °C with a 5 °C/min heating rate. 
2.2. Scaffolds Fabrication 
The scaffolds were prepared by mixing the HA/BG_Ca powders with a thermally removable 
organic phase acting as a pore generating agent. With this aim, polyethylene (PE) powders (Goonvean 
Fibres, U.K.) mixtures with the following composition were employed: 80 wt % PE powders with 
particle size within 90–150 μm and 20 wt % PE powders with particle size within 300–500 μm. 50% vol. 
of HA/BG_Ca powders were added to 50% vol. of PE powders, and the obtained mixture was further 
mixed for 30 min. in a plastic bottle using a rolls shaker. Then the powders were used to produce green 
bodies by uniaxial pressing at 140 MPa for 10 s using propanol as a liquid binder. The pressed 
samples, shaped in form of disks (4 cm of diameter, 0.7 cm of thickness), were heat-treated in a 
furnace in order to burn out the PE powders and sinter the inorganic phase. The thermal treatment was 
set at a final temperature of 750 °C for 3 h. The heating rate was 5 °C/min.  
2.3. HA/BG_Ca Composites Characterization 
Fine BG_Ca powders were first employed for the Differential Thermal Analysis (DTA). DTA 
(Netzsch DSC 404 differential thermal analyzer) was performed by using 30 mg of powders heated 
from room temperature to 1300 °C at 10 °C/min, in order to obtain the critical temperatures of the 
glass, such as the glass transition, crystallization and melting temperatures.  
The in vitro bioactivity of the HA/BG_Ca samples was investigated by soaking them in a simulated 
body fluid (SBF) solution, according to the standard protocol developed by Kokubo et al. [36]. SBF 
has inorganic ion concentrations similar to those of the human extracellular fluid. The samples were 
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immersed in polyethylene flasks containing 20 mL of SBF and maintained at 37 °C. The SBF was 
refreshed every two days. After given times of 1, 3, 7 and 14 days the samples were extracted from the 
solution, rinsed with deionized water and then left to dry at room temperature.  
The sample microstructure before and after soaking in SBF was investigated by means of a 
scanning electron microscope, ESEM (ESEM Quanta 2000, FEI Co., Eindhoven, Netherlands). 
Moreover, a local chemical analysis was performed by X-ray Energy Dispersion Spectroscopy, EDS 
(Inca, Oxford Instruments, U.K.). The SEM was operated in low-vacuum mode with a pressure of 
0.5 Torr. 
The samples were also studied by means of X-ray diffraction (XRD). The samples were analyzed 
with a PANalytical X’pert PRO diffractometer employing a Cu kα radiation. Data were collected in 
the angular range 10–70° 2θ with steps of 0.017° and a scanning rate of 0.02° s−1. 
2.4. Scaffolds Characterization 
The scaffolds microstructure was investigated by means of a scanning electron microscope. 
Particular attention was devoted to the morphology, distribution and interconnection of pores.  
The total porosity (vol. %) of the scaffolds was evaluated by the following calculation 
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where P% is the total porosity (vol. %), Wf is the measured weight of the scaffold and W0 is the 
theoretical one, calculated from the product of the HA/BG_Ca density by the scaffold volume. The 
density  = 2.99 g/cm3 of the composite was measured by means of a pycnometer test (Micromeritics 
AccuPyc 1330, Georgia, U.S.). Optical microscope images were also considered and analyzed with the 
aim to validate the porosity values. In particular, for each kind of scaffold, at least five images were 
acquired with an optical microscope equipped with a 10× objective. The area occupied by the pores 
was quantified by means of image analysis (UTHSCSA Image Tool). 
Qualitative capillarity tests were performed on the scaffolds to assess their permeability, i.e., the 
presence of a highly interconnected pores network. To this aim, a solution with a viscosity (density 
~1.05 g/cm
3
 [39], viscosity ~3.5 mPa·s [40]) similar to that of the human blood was used. Some drops 
of blue ink were dispersed into the solution to better observe the fluid infiltration throughout 
the scaffold.  
The mechanical resistance of the scaffolds was measured by means of compression tests (Zwick 
Roell Z600, equipped with an electronic estensimeter). The samples were indicatively 40 mm large 
and 7 mm thick disks. The load was applied along the thickness direction. The cross-head speed was 
set at 0.01 mm/min and the stress-deformation curve was recorded up to the maximum stress point. In 
particular, the failure stress f was defined as 

 f 
L
A
 (2)  
where L (N) was the maximum applied load and A (mm
2
) was the nominal area of the cross section 
perpendicular to the load axis. For each type of material, five samples were considered to have 
statistical data.  
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3. Results and Discussion 
3.1. HA/BG_Ca Composites Characterization 
Differential thermal analyses (Figure 1) indicated that the BG_Ca glass had a Tg at around 710 °C, 
an exothermal peak Tc at around 850 °C, and an endothermic peak Tm at around 1140 °C.  
Tc corresponds to the glass crystallization, while Tm may be attributed to the melting of the  
crystalline phase. 
Figure 1. Differential thermal analysis of the BG_Ca glass (heating rate 10 °C/min). 
 
 
Analogous studies regarding the widely used 45S5 Bioglass
®
 [41] report a lower crystallization 
onset temperature, at around 600 °C. The novel composition’s reduced tendency to crystallize 
compared to the 45S5 Bioglass
®
 can be attributed to its low sodium content. Crystallization, in fact, is 
regulated by two interactive factors: the viscosity of the glassy matrix and the diffusion coefficients of 
the ions which form the crystalline texture. Crystal nucleation and viscosity are both diffusion-related 
processes. Sodium is a glass-network modifier, capable of lowering the viscosity of silicate glasses by 
increasing the number of non-bridging oxygens [42,43]. This behavior can also favor crystallization. 
From this point of view, a decrease of all transformation temperatures—including the onset of 
melting—with an increase of the sodium content is reported in literature for different silicate-glass 
compositions [44]. Since the crystallization can slow down and hinder the kinetics of the sintering 
process, the BG_Ca powders are expected to consolidate at relatively low temperatures, which would 
be inadequate to confer a comparable compactness to a 45S5 Bioglass
®
 sample. Preliminary tests 
carried out on BG_Ca powders confirmed this property. The glass ability to maintain its amorphous 
nature up to very high temperatures is confirmed by the XRD analysis (Figure 2) performed on the 
BG_Ca sintered sample, treated at 750 °C for 3 hours. The pattern is characterized by a broad halo, 
indicating that the glass was completely amorphous. 
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Figure 2. XRD spectra of the BG_Ca sintered sample treated at 750 °C for 3 hours. 
 
 
Figure 3 reports some representative micrographs of the surface of a HA/BG_Ca specimen (sintered 
at 750 °C) at different magnification degrees. In general, the constituent phases are quite 
homogeneously distributed and the composite is well consolidated. Figure 4 shows a micrograph of a 
HA/BG_Ca specimen with the corresponding EDS spectra. The high Ca/Na ratio should be noted.  
Figure 3. Micrographs of the surface of a HA/BG_Ca sample (different magnification 
degrees) treated at 750 °C for 3 hours. 
 
 
Great attention was paid to the in vitro behavior of the composites. In fact, since the formation 
in vivo of a HA layer at the interface between bone and implanted device is necessary for prostheses 
integration, the in vitro development of such a layer is usually considered as a fundamental 
preliminary requirement. Once immersed in a simulated body fluid solution, the composite starts its 
dissolution process. After soaking in SBF for 3 days, the composite is covered by a silica gel layer and 
it is possible to observe globular precipitates with the typical HA morphology, which are progressively 
growing and diffusing on the entire surface. After 7 days in SBF (Figure 5) the samples are entirely 
covered by HA. This fact is also confirmed by the EDS results reported in Figure 5, which show the 
presence of Ca and P in proportions similar to that of stoichiometric HA, since the Ca/P ratio is about 
1.7 while in stoichiometric HA it is 1.67 [45]. Although Si is still present, as a result of the silica gel 
underneath the precipitates, its content appears lower because of the thicker HA layer above it. The 
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HA precipitation has reached a much more advanced stage after 14 days in SBF (Figure 6). In fact, the 
original surface of the composite material is no longer recognizable.  
Figure 4. (a) Micrograph of a HA/BG_Ca specimen treated at 750 °C for 3 hours and  
(b) EDS results of the analysis carried out on the whole area reported. 
 
 
Figure 5. (a, b) Micrographs of a HA/BG_Ca sample (treated at 750 °C for 3 hours ) after  
7 days in SBF and (c) EDS results of the analysis carried out on the whole area reported in (b). 
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Figure 6. (a) Micrograph of the surface of a HA/BG_Ca sample (treated at 750 °C for 
3 hours) after 14 days in SBF; (b) detail of the precipitated hydroxyapatite on the  
sample surface. 
 
 
The XRD analysis of the HA/BG_Ca composite before and after soaking in SBF is presented in 
Figure 7. The spectrum of the as-produced sample before and after immersion in SBF reveals only HA 
peaks; therefore the low temperature treatment minimizes the reaction between glass and HA. On the 
other hand, as reported in the introduction, literature regarding HA/bioactive glass composites often 
reports a complete reaction between glass and HA, resulting in an exhaustion, or at least a reduction, 
of the HA amount [27,30,46]. A slight broadening of the HA peaks with increasing soaking time is due 
to the micro-crystalline nature of the new HA precipitates [47]. On the basis of these interesting 
results, in vivo bioactivity of the HA/BG_Ca composite can also be expected. 
Figure 7. XRD spectra of the HA/BG_Ca composite treated at 750 °C for 3 hours before 
and after soaking in SBF. 
 
3.2. Scaffolds Characterization 
Preliminary studies were focused on the feasibility of fabricating porous scaffolds with various PE 
contents. Several PE-to-composite HA/BG_Ca powders ratios were considered and it was found that 
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after adding PE contents higher than 70 vol. % it was not possible to produce samples strong enough to 
be handled without damage. On the other hand, PE contents lower than 30 vol. % were insufficient to 
induce an adequate porosity [48]. In this study the microstructure of scaffolds realized using 50% vol. 
of HA/BG_Ca powders and 50% vol. of PE powders is offered as an example. The obtained samples 
are reported in Figure 8. 
Figure 8. Digital image of a HA/BG_Ca scaffold treated at 750 °C for 3 hours. 
 
 
Figure 9 shows the scaffold internal microstructure, revealing a distribution of large pores, as well 
as a high degree of interconnection between the pores. These features are crucial to foster an adequate 
vascularization and cell penetration in vivo [7]. It should be noted that the scaffolds were produced 
with mixtures of large (300–500 μm) and small (90–150 μm) PE particles. This is the reason why they 
exhibit not only interconnected macro-pores, but also a widespread network of micro-pores. The 
porosity is further augmented by the gas phases developed during the thermal decomposition of the PE 
spheres. The average pore size is greater than 100 μm, which is considered to be the minimum value 
required to allow bone cell infiltration and tissue in-growth [7]. In particular, in Figure 9(d) it is 
possible to observe that a good sintering level has been achieved and the struts between pores are 
well densified. 
The average total porosity, calculated using Equations (1) on three samples is about 60 vol. %. This 
value was also confirmed by image analysis. However this technique, based on 2D images, is rather 
approximate, since the real porosity is intrinsically 3-dimensional. Preliminary samples obtained 
adding PE contents higher than 50 vol. % showed a higher porosity, reaching 70 vol. % (60 vol. % PE 
content), which is rather satisfactory for a burning out approach, especially in comparison to the results 
commonly reported in the literature, where typical values of 50 vol. %, or even less, are often  
reported [48,49]. 
Figure 10 reports the outcomes of the capillarity tests performed on the produced samples in order 
to qualitatively investigate their permeability. A face of the scaffold was put into contact with the 
solution, previously colored by adding some drops of blue ink. The fluid infiltration within the 
scaffold, driven by capillarity forces, was immediately observed.  
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Figure 9. Micrographs of the HA/BG_Ca scaffolds microstructure: detail of the internal 
structure at different magnification degrees. The sample was treated at 750 °C for 3 hours. 
 
 
Figure 10. Images of the scaffold during the capillarity test. The sample was treated at  
750 °C for 3 hours. 
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A typical stress-deformation curve for the obtained scaffolds is reported in Figure 11 together with 
a schematic representation of the compression tests layout. It is possible to observe a positive slope up 
to a peak point that identifies the failure stress f (see Equation 2). After that, an apparent stress drop 
occurs due to the collapse of the first struts. However it should be noted that the sample is still able to 
withstand higher loads, since the cracking phenomena at f only involves the weakest trabeculae 
among pores. From this point of view, this definition of the failure stress f is conservative, since it 
represents the limit of the Hookean-like region and not the complete breakdown of the scaffolds. The 
failure stress is 120.7 ± 2.1 MPa; this value is very high with respect to those usually reported in the  
literature [50]. However a similar behavior was reported by Baino and coworkers for high-resistance 
scaffolds obtained via powder pressing and burning out [51]. In particular, they observed an 
anisotropic mechanical response of the samples, i.e., the scaffold resistance was superior if the load 
was applied along the compaction direction (as is the case in the present contribution) or along a 
transversal direction. This fact is probably due to the elongated shape of the pores, which resulted from 
the deformation of the PE particles caused by the pressure applied to the powders. Analogously, the 
high resistance observed during the mechanical tests performed in the present work could be attributed 
to a similar preferential orientation of pores.  
Figure 11. (a) Schematic representation of the compression tests layout. (b) Stress-deformation 
curve for a scaffold treated at 750 °C for 3 hours. 
 
 
The porosity achieved in this feasibility study, the preserved amorphous nature of the glassy phase 
and the lack of HA thermal decomposition (and reaction) make the new HA/BG_Ca composite an 
intriguing system for the production of high-quality scaffolds. In particular, the possibility to employ 
this mixture to realize scaffolds by means of the widely used replication technique [4], which involves 
the production of ceramic foams by coating a polymeric sponge, is under investigation.  
4. Conclusions and Perspectives  
In this work, for the first time, glass-reinforced HA composites were produced employing BG_Ca, a 
glass composition belonging to the Na2O-CaO-P2O5-SiO2 system. This glass offers two basic 
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advantages: it can be sintered at a relatively low temperature (750 °C) and it can preserve its 
amorphous nature up to 800 °C. In this way, the production of HA/BG_Ca composites is easier than 
standard HA/Bioglass ones. In fact, the HA/BG_Ca composites (in the present research: 50 wt % 
BG_Ca-50 wt % HA) can be sintered at 750 °C, while the standard HA/45S5Bioglass
®
 systems are 
usually treated at higher temperatures to achieve an adequate consolidation, typically in the 
1150-1300 °C range. Such drastic thermal treatments are likely to cause the HA to decompose and to 
cause the bioactive glass to crystallize into a glass ceramic. This fact, in particular, can potentially 
delay the bioactivity of the resulting samples. From this point of view the novel composites, which can 
be sintered without modifying the amorphous nature of the glass and the original composition of the 
HA, present a surprisingly high in vitro bioactivity.  
As a first application, the obtained composites were used to realize highly porous scaffolds by 
means of the polymer burning out method, which combines simplicity, versatility and low cost. The 
obtained samples are characterized by an open and interconnected pore network, with an average pore 
size higher than 100 μm. All the pores showed dense sintered struts. Such a microstructure provides 
adequate properties in term of permeability to fluids, verified by a capillarity test, together with an 
appreciable mechanical behavior according to compression tests.  
Further studies on HA/BG_Ca composites are under investigation, mainly regarding their in vitro 
degradation. In particular, it would be interesting to perform special immersion tests in SBF in order to 
evaluate the concentration of the elements released by the composites by means of inductively coupled 
plasma analysis. Moreover, in order to evaluate the effect of the immersion in SBF on the mechanical 
reliability of the composites, their microhardness will be measured before and after treatment; in the 
same way, compression tests will be performed on HA/BG_Ca-based scaffolds after different soaking 
intervals in SBF. Finally, the obtained results will be compared with the degradation behavior of 
BG_Ca-based scaffolds, with the aim to evaluate the effect of HA in the composite.  
The application of HA/BG_Ca composites to produce scaffolds by means of the replication 
technique is also in progress. Such a method, which reproduces the desired pore network directly in a 
ceramic matrix, overcomes the limits of the polymer burning out technique.  
Moreover, the new composite opens interesting scenarios for further applications in the 
development of prosthesis; in this sense, for example, it would be interesting to investigate the 
possibility to coat metallic substrates with HA/BG_Ca in order to make them bioactive. These results 
will be the subject of future studies.  
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